Reply to thread

The Japs are in the midst of a 2 year plan of divesting themselves of all their dead weight divisions. Once they shrink the company down to a lean and relatively profitable US Pharma company, they will spin it off and be done with it. The recently announced cuts were the 1st phase of this plan.